These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 20819537

  • 1. Nifekalant hydrochloride terminating sustained ventricular tachycardia accompanied with QT dispersion prolongation.
    Wang J, Hua W, Zhu J, Yang YM, Wang FZ, Pu JL, Chen KP, Zhang S.
    Chin Med J (Engl); 2010 Aug 05; 123(15):2028-33. PubMed ID: 20819537
    [Abstract] [Full Text] [Related]

  • 2. [Efficacy of Nifekalant hydrochloride for life-threatening ventricular tachyarrhythmias in patients with resistance to lidocaine: a study of patients with out-of-hospital cardiac arrest].
    Amino M, Yoshioka K, Iwata O, Fujikura H, Deguchi Y, Ban K, Shiina Y, Goto S, Handa S, Tanabe T, Nakagawa Y, Morita S, Iwase H, Yamamoto I, Inokuchi S, Marutani Y.
    J Cardiol; 2003 Mar 05; 41(3):127-34. PubMed ID: 12674997
    [Abstract] [Full Text] [Related]

  • 3. Nifekalant versus lidocaine for in-hospital shock-resistant ventricular fibrillation or tachycardia.
    Shiga T, Tanaka K, Kato R, Amino M, Matsudo Y, Honda T, Sagara K, Takahashi A, Katoh T, Urashima M, Ogawa S, Takano T, Kasanuki H, Refractory VT/VF, Prospective Evaluation to Differentiate Lidocaine Efficacy from Nifekalant (RELIEF) Study Investigators.
    Resuscitation; 2010 Jan 05; 81(1):47-52. PubMed ID: 19913983
    [Abstract] [Full Text] [Related]

  • 4. [Nifekalant hydrochloride effective against perioperative ventricular tachycardia in patients with impaired left ventricular function].
    Murakami T, Makino Y, Kato H.
    Kyobu Geka; 2007 Jun 05; 60(6):469-73. PubMed ID: 17564063
    [Abstract] [Full Text] [Related]

  • 5. [Nifekalant hydrochloride as an effective treatment for postoperative ischemic heart disease].
    Enomoto Y, Aoki K, Toshimitsu Y, Inai Y, Asakura T, Furuta S.
    Kyobu Geka; 2005 Apr 05; 58(4):316-9. PubMed ID: 15828253
    [Abstract] [Full Text] [Related]

  • 6. Prevention of life-threatening ventricular tachyarrhythmia by a novel and pure class-III agent, nifekalant hydrochloride.
    Ohashi J, Yasuda S, Miyazaki S, Shimizu W, Morii I, Kurita T, Kawamura A, Kamakura S, Nonogi H.
    J Cardiovasc Pharmacol; 2006 Dec 05; 48(6):274-9. PubMed ID: 17204905
    [Abstract] [Full Text] [Related]

  • 7. [Treatment for perioperative arrhythmias with nifekalant hydrochloride].
    Nishida M, Okada H, Murakami M, Hamano K.
    Kyobu Geka; 2006 Mar 05; 59(3):210-3. PubMed ID: 16528993
    [Abstract] [Full Text] [Related]

  • 8. [Clinical experience with intravenous administration of nifekalant hydrochloride for ventricular tachycardia in a hemodialysis patient after open heart surgery].
    Furukawa H, Aono H, Samukawa M, Iwasaki K, Ohkado A.
    Kyobu Geka; 2010 Oct 05; 63(11):988-91. PubMed ID: 20954355
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of nifekalant hydrochloride in the treatment of fatal ventricular arrhythmia in patients with ischemic heart disease.
    Ando J, Kakishita M, Sakai K, Komura Y, Nishiyama K, Iwabuchi M, Yokoi H, Yasumoto H, Nosaka H, Nobuyoshi M.
    Int Heart J; 2005 Jul 05; 46(4):647-56. PubMed ID: 16157956
    [Abstract] [Full Text] [Related]

  • 10. Anti-arrhythmic efficacy of nifekalant hydrochloride, a pure class III anti-arrhythmic agent, in patients with healed myocardial infarction and inducible sustained ventricular tachycardia.
    Igawa M, Aonuma K, Okamoto Y, Hiroe M, Hiraoka M, Isobe M.
    J Cardiovasc Pharmacol; 2002 Nov 05; 40(5):735-42. PubMed ID: 12409982
    [Abstract] [Full Text] [Related]

  • 11. [Successful administration of nifekalant hydrochloride for postoperative junctional ectopic tachycardia in congenital cardiac surgery].
    Sasaki T, Nemoto S, Ozawa H, Katsumata T, Ozaki N, Okumura K, Katayama H, Tamai H, Kishida H.
    Kyobu Geka; 2007 Oct 05; 60(11):1022-6. PubMed ID: 17926908
    [Abstract] [Full Text] [Related]

  • 12. [The efficiency of nifekalant hydrochloride for the prevention of ventricular tachycardia during cardiac surgery].
    Sakaguchi M, Takemura T, Shimamura Y, Tsuda Y, Iwasa S.
    Kyobu Geka; 2004 Mar 05; 57(3):191-5. PubMed ID: 15035072
    [Abstract] [Full Text] [Related]

  • 13. Effect of nifekalant for acute conversion of atrial flutter: the possible termination mechanism of typical atrial flutter.
    Morita N, Tanaka K, Yodogawa K, Hayashi M, Akutsu K, Yamamoto T, Satoh N, Kobayashi Y, Katoh T, Takano T.
    Pacing Clin Electrophysiol; 2007 Oct 05; 30(10):1242-53. PubMed ID: 17897127
    [Abstract] [Full Text] [Related]

  • 14. Nifekalant and disopyramide in a patient with short QT syndrome: evaluation of pharmacological effects and electrophysiological properties.
    Mizobuchi M, Enjoji Y, Yamamoto R, Ono T, Funatsu A, Kambayashi D, Kobayashi T, Nakamura S.
    Pacing Clin Electrophysiol; 2008 Sep 05; 31(9):1229-32. PubMed ID: 18834480
    [Abstract] [Full Text] [Related]

  • 15. [Role of determination of QT dispersal intervals in anti-arrhythmia therapy].
    Konecná P, Dvorák R, Semrád B.
    Vnitr Lek; 1999 Aug 05; 45(8):453-6. PubMed ID: 11045143
    [Abstract] [Full Text] [Related]

  • 16. Experience with nifekalant hydrochloride in a patient with ischemic cardiomyopathy and severe ventricular dysfunction after dor operation.
    Kokaji K, Okamoto M, Hotoda K, Kumamaru H.
    Jpn Heart J; 2004 Jul 05; 45(4):691-5. PubMed ID: 15353881
    [Abstract] [Full Text] [Related]

  • 17. Effects of intravenous nifekalant as a lifesaving drug for severe ventricular tachyarrhythmias complicating acute coronary syndrome.
    Yusu S, Ikeda T, Mera H, Miyakoshi M, Miwa Y, Abe A, Tsukada T, Ishiguro H, Shimizu H, Yoshino H.
    Circ J; 2009 Nov 05; 73(11):2021-8. PubMed ID: 19724153
    [Abstract] [Full Text] [Related]

  • 18. [Prediction of long-term efficacy of amiodarone for refractory ventricular tachycardia: clinical significance of electrophysiologic study and Holter monitoring].
    Tsuchiya M, Kasanuki H, Ohnishi S, Hosoda S.
    J Cardiol; 1996 Nov 05; 28(5):267-76. PubMed ID: 8953400
    [Abstract] [Full Text] [Related]

  • 19. The effects of nifekalant hydrochloride on the QT dispersion after direct-current defibrillation.
    Maeda K, Takagi M, Tatsumi H, Nakagawa E, Yoshiyama M.
    Osaka City Med J; 2008 Jun 05; 54(1):11-9. PubMed ID: 18819261
    [Abstract] [Full Text] [Related]

  • 20. Excessive increase in QT interval and dispersion of repolarization predict recurrent ventricular tachyarrhythmia after amiodarone.
    Aiba T, Shimizu W, Inagaki M, Satomi K, Taguchi A, Kurita T, Suyama K, Aihara N, Sunagawa K, Kamakura S.
    Pacing Clin Electrophysiol; 2004 Jul 05; 27(7):901-9. PubMed ID: 15271008
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.